TLPHTalphera, Inc.

$18M

Q2 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$3M+210.7% YoY

Gross Profit

$2M53.1% margin

Operating Income

-$7M-233.7% margin

Net Income

-$7M-225.9% margin

EPS (Diluted)

$-1.64

QoQ Revenue Growth

+657.5%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$67M

Total Liabilities

$128M

Stockholders' Equity

-$60M

Cash & Equivalents

$22M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$941,000	+210.7%
Gross Profit	$2M	-$2M	+176.5%
Operating Income	-$7M	-$13M	+48.9%
Net Income	-$7M	-$12M	+46.8%

TLPH Q2 2020 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena